#PATHFINDERII

PATHFINDER II: assessing the efficacy and safety of a MCAD test - VJOncology Nima Nabavizadeh, MD, Oregon Health & Science University, Portland, OR, discusses the PATHFINDER II study (NCT05155605), evaluating a multi-cancer early...

Nima Nabavizadeh, MD, presents #PATHFINDERII data on multi-cancer early detection.

🧬 cfDNA test detects cancer signal & origin
📈 High specificity & PPV
⚕️ Boosted early-stage cancer detection

🎥 buff.ly/LDR0AgW

#CancerScreening #Oncology #ESMO25